The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 2, 2025 | Wood Gavin | Chief Financial Officer | Sell(S) | 96K | $0.01 | $960 |
| Aug 28, 2025 | Bertrand William C JR | Chief Operating Officer | Sell(S) | 207K | $0.01 | $2K |
| Aug 18, 2025 | Behbahani Ali | Director | Sell(S) | 14.7M | $0.01 | $147K |
| Aug 15, 2025 | Behbahani Ali | Director | Sell(S) | 4.8M | $0.01 | $48K |
| Jul 30, 2025 | EcoR1 Capital, LLC | 10% Owner | Sell(S) | 27.4M | $0.10 | $2.7M |
| Jul 29, 2025 | EcoR1 Capital, LLC | 10% Owner | Sell(S) | 2.7M | $0.10 | $269K |
| Jul 28, 2025 | EcoR1 Capital, LLC | 10% Owner | Sell(S) | 33.9M | $0.11 | $3.7M |
| Feb 20, 2025 | Rawcliffe Adrian | Chief Executive Officer, Director | Grant(A) | 5.1M | — | $0 |
| Feb 20, 2025 | Rawcliffe Adrian | Chief Executive Officer, Director | Grant(A) | 3.4M | — | $0 |
| Feb 20, 2025 | Norry Elliot | Chief Medical Officer | Grant(A) | 1.1M | — | $0 |
| Feb 20, 2025 | Norry Elliot | Chief Medical Officer | Grant(A) | 1.6M | — | $0 |
| Feb 20, 2025 | Piccina Cintia | Chief Commercial Officer | Grant(A) | 1.6M | — | $0 |
| Feb 20, 2025 | Piccina Cintia | Chief Commercial Officer | Grant(A) | 1.1M | — | $0 |
| Feb 20, 2025 | Lunger John | Chief Patient Supply Officer | Grant(A) | 1.6M | — | $0 |
| Feb 20, 2025 | Lunger John | Chief Patient Supply Officer | Grant(A) | 1.1M | — | $0 |
| Feb 20, 2025 | Brewer Joanna Elizabeth | Chief Scientific Officer | Grant(A) | 1.1M | — | $0 |
| Feb 20, 2025 | Brewer Joanna Elizabeth | Chief Scientific Officer | Grant(A) | 1.6M | — | $0 |
| Feb 20, 2025 | Bertrand William C JR | Chief Operating Officer | Grant(A) | 1.6M | — | $0 |
| Feb 20, 2025 | Bertrand William C JR | Chief Operating Officer | Grant(A) | 1.1M | — | $0 |
| Jan 17, 2025 | Rawcliffe Adrian | Chief Executive Officer, Director | Sell(S) | 31K | $0.58 | $18K |
| Jan 17, 2025 | Bertrand William C JR | Chief Operating Officer | Sell(S) | 6K | $0.58 | $3K |
| Jan 17, 2025 | Lunger John | Chief Patient Supply Officer | Sell(S) | 6K | $0.58 | $3K |
| Jan 17, 2025 | Norry Elliot | Chief Medical Officer | Sell(S) | 6K | $0.58 | $3K |
| Jan 15, 2025 | Bertrand William C JR | Chief Operating Officer | Sell(S) | 10K | $0.57 | $6K |
| Jan 15, 2025 | Lunger John | Chief Patient Supply Officer | Sell(S) | 10K | $0.57 | $6K |
| Jan 15, 2025 | Norry Elliot | Chief Medical Officer | Sell(S) | 10K | $0.57 | $6K |
| Jan 15, 2025 | Piccina Cintia | Chief Commercial Officer | Sell(S) | 13K | $0.57 | $7K |
| Jan 15, 2025 | Rawcliffe Adrian | Chief Executive Officer, Director | Sell(S) | 29K | $0.57 | $17K |
| Jan 13, 2025 | Bertrand William C JR | Chief Operating Officer | Sell(S) | 5K | $0.59 | $3K |
| Jan 13, 2025 | Bertrand William C JR | Chief Operating Officer | Sell(S) | 4K | $0.59 | $3K |
| Jan 13, 2025 | Lunger John | Chief Patient Supply Officer | Sell(S) | 5K | $0.59 | $3K |
| Jan 13, 2025 | Lunger John | Chief Patient Supply Officer | Sell(S) | 4K | $0.59 | $3K |
| Jan 13, 2025 | Norry Elliot | Chief Medical Officer | Sell(S) | 4K | $0.59 | $3K |
| Jan 13, 2025 | Norry Elliot | Chief Medical Officer | Sell(S) | 8K | $0.59 | $5K |
| Jan 13, 2025 | Rawcliffe Adrian | Chief Executive Officer, Director | Sell(S) | 13K | $0.59 | $7K |
| Jan 13, 2025 | Rawcliffe Adrian | Chief Executive Officer, Director | Sell(S) | 18K | $0.59 | $11K |
| Jul 1, 2024 | Behbahani Ali | Director | Grant(A) | 1.1M | — | $0 |
| Jul 1, 2024 | Allen Andrew R | Director | Grant(A) | 660K | — | $0 |
| Jul 1, 2024 | Alleva Lawrence M | Director | Grant(A) | 1.2M | — | $0 |
| Jul 1, 2024 | Furey John | Director | Grant(A) | 660K | — | $0 |
| Jul 1, 2024 | Hegde Priti | Director | Grant(A) | 1.1M | — | $0 |
| Jul 1, 2024 | Hege Kristen | Director | Grant(A) | 660K | — | $0 |
| Jul 1, 2024 | Menzel Garry E | Director | Grant(A) | 1.1M | — | $0 |
| Jul 1, 2024 | Mott David M | Director | Grant(A) | 1.6M | — | $0 |
| Jun 18, 2024 | Piccina Cintia | Chief Commercial Officer | Sell(S) | 25K | $0.93 | $23K |
| Mar 18, 2024 | Piccina Cintia | Chief Commercial Officer | Grant(A) | 1.1M | — | $0 |
| Mar 18, 2024 | Piccina Cintia | Chief Commercial Officer | Grant(A) | 5.1M | — | $0 |
| Jan 17, 2024 | Bertrand William C JR | Chief Operating Officer | Sell(S) | 14K | $0.67 | $9K |
| Jan 17, 2024 | Bertrand William C JR | Chief Operating Officer | Sell(S) | 5K | $0.67 | $4K |
| Jan 17, 2024 | Lunger John | Chief Patient Supply Officer | Sell(S) | 5K | $0.67 | $4K |
| Jan 17, 2024 | Lunger John | Chief Patient Supply Officer | Sell(S) | 13K | $0.67 | $9K |
| Jan 17, 2024 | Norry Elliot | Chief Medical Officer | Sell(S) | 5K | $0.67 | $4K |
| Jan 17, 2024 | Norry Elliot | Chief Medical Officer | Sell(S) | 13K | $0.67 | $9K |
| Jan 17, 2024 | Rawcliffe Adrian | Chief Executive Officer, Director | Sell(S) | 30K | $0.67 | $20K |
| Jan 16, 2024 | Bertrand William C JR | Chief Operating Officer | Sell(S) | 5K | $0.79 | $4K |
| Jan 16, 2024 | Lunger John | Chief Patient Supply Officer | Sell(S) | 5K | $0.79 | $4K |
| Jan 16, 2024 | Norry Elliot | Chief Medical Officer | Sell(S) | 2K | $0.79 | $2K |
| Jan 16, 2024 | Rawcliffe Adrian | Chief Executive Officer, Director | Sell(S) | 9K | $0.79 | $7K |
| Jan 15, 2024 | Rawcliffe Adrian | Chief Executive Officer, Director | Grant(A) | 7.6M | — | $0 |
| Jan 15, 2024 | Rawcliffe Adrian | Chief Executive Officer, Director | Grant(A) | 1.7M | — | $0 |
| Jan 15, 2024 | Norry Elliot | Chief Medical Officer | Grant(A) | 2.5M | — | $0 |
| Jan 15, 2024 | Norry Elliot | Chief Medical Officer | Grant(A) | 565K | — | $0 |
| Jan 15, 2024 | Wood Gavin | Chief Financial Officer | Grant(A) | 565K | — | $0 |
| Jan 15, 2024 | Wood Gavin | Chief Financial Officer | Grant(A) | 2.5M | — | $0 |
| Jan 15, 2024 | Tayton-Martin Helen Katrina | Chief Business & Strgy Officer | Grant(A) | 2.5M | — | $0 |
| Jan 15, 2024 | Tayton-Martin Helen Katrina | Chief Business & Strgy Officer | Grant(A) | 565K | — | $0 |
| Jan 15, 2024 | Brewer Joanna Elizabeth | Chief Scientific Officer | Grant(A) | 2.5M | — | $0 |
| Jan 15, 2024 | Brewer Joanna Elizabeth | Chief Scientific Officer | Grant(A) | 565K | — | $0 |
| Jan 15, 2024 | Lunger John | Chief Patient Supply Officer | Grant(A) | 565K | — | $0 |
| Jan 15, 2024 | Lunger John | Chief Patient Supply Officer | Grant(A) | 2.5M | — | $0 |
| Jan 15, 2024 | Hege Kristen | Director | Grant(A) | 82K | — | $0 |
| Jan 15, 2024 | Bertrand William C JR | Chief Operating Officer | Grant(A) | 565K | — | $0 |
| Jan 15, 2024 | Bertrand William C JR | Chief Operating Officer | Grant(A) | 2.5M | — | $0 |
| Jan 15, 2024 | Behbahani Ali | Director | Grant(A) | 41K | — | $0 |
| Jan 12, 2024 | Rawcliffe Adrian | Chief Executive Officer, Director | Sell(S) | 17K | $0.85 | $15K |
| Jan 12, 2024 | Norry Elliot | Chief Medical Officer | Sell(S) | 8K | $0.85 | $7K |
| Jan 12, 2024 | Lunger John | Chief Patient Supply Officer | Sell(S) | 5K | $0.85 | $4K |
| Jan 12, 2024 | Bertrand William C JR | Chief Operating Officer | Sell(S) | 5K | $0.85 | $4K |
| Jan 11, 2024 | Rawcliffe Adrian | Chief Executive Officer, Director | Sell(S) | 12K | $0.84 | $10K |
| Jan 11, 2024 | Norry Elliot | Chief Medical Officer | Sell(S) | 4K | $0.84 | $3K |
| Jan 11, 2024 | Lunger John | Chief Patient Supply Officer | Sell(S) | 4K | $0.84 | $3K |
| Jan 11, 2024 | Bertrand William C JR | Chief Operating Officer | Sell(S) | 4K | $0.84 | $3K |
| Sep 1, 2023 | Rawcliffe Adrian | Chief Executive Officer, Director | Sell(S) | 2K | $0.78 | $2K |
| Aug 1, 2023 | Lunger John | Chief Patient Supply Officer | Sell(S) | 3K | $0.91 | $3K |
| Jul 10, 2023 | Menzel Garry E | Director | Sell(S) | 48K | $0.91 | $43K |
| Jul 5, 2023 | Menzel Garry E | Director | Grant(A) | 2.7M | — | $0 |
| Jul 5, 2023 | Menzel Garry E | Director | Grant(A) | 58K | — | $0 |
| Jul 5, 2023 | Menzel Garry E | Director | Grant(A) | 3.6M | — | $0 |
| Jul 5, 2023 | Menzel Garry E | Director | Grant(A) | 360K | — | $0 |
| Jul 5, 2023 | Menzel Garry E | Director | Grant(A) | 1.3M | — | $0 |
| Jul 5, 2023 | Menzel Garry E | Director | Grant(A) | 737K | — | $0 |
| Jul 5, 2023 | Menzel Garry E | Director | Grant(A) | 2.2M | — | $0 |
| Jul 5, 2023 | Allen Andrew R | Director | Grant(A) | 57K | — | $0 |
| Jul 5, 2023 | Allen Andrew R | Director | Grant(A) | 152K | — | $0 |
| Jul 5, 2023 | Allen Andrew R | Director | Grant(A) | 110K | — | $0 |
| Jul 5, 2023 | Allen Andrew R | Director | Grant(A) | 110K | — | $0 |
| Jul 5, 2023 | Allen Andrew R | Director | Grant(A) | 45K | — | $0 |
| Jul 5, 2023 | Allen Andrew R | Director | Grant(A) | 73K | — | $0 |
| Jul 5, 2023 | Hegde Priti | Director | Grant(A) | 226K | — | $0 |
| Jul 5, 2023 | Hegde Priti | Director | Grant(A) | 110K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).